Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5CQD

Crystal Structure of the Cancer Genomic DNA Mutator APOBEC3B

5CQD の概要
エントリーDOI10.2210/pdb5cqd/pdb
関連するPDBエントリー5CQH 5CQI 5CQK
分子名称DNA dC->dU-editing enzyme APOBEC-3B, ZINC ION, GLYCEROL, ... (4 entities in total)
機能のキーワードapobec, deaminase, hydrolase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数2
化学式量合計44549.21
構造登録者
Shi, K.,Kurahashi, K.,Aihara, H. (登録日: 2015-07-21, 公開日: 2015-10-07, 最終更新日: 2023-09-27)
主引用文献Shi, K.,Carpenter, M.A.,Kurahashi, K.,Harris, R.S.,Aihara, H.
Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.
J.Biol.Chem., 290:28120-28130, 2015
Cited by
PubMed Abstract: Functional and deep sequencing studies have combined to demonstrate the involvement of APOBEC3B in cancer mutagenesis. APOBEC3B is a single-stranded DNA cytosine deaminase that functions normally as a nuclear-localized restriction factor of DNA-based pathogens. However, it is overexpressed in cancer cells and elicits an intrinsic preference for 5'-TC motifs in single-stranded DNA, which is the most frequently mutated dinucleotide in breast, head/neck, lung, bladder, cervical, and several other tumor types. In many cases, APOBEC3B mutagenesis accounts for the majority of both dispersed and clustered (kataegis) cytosine mutations. Here, we report the first structures of the APOBEC3B catalytic domain in multiple crystal forms. These structures reveal a tightly closed active site conformation and suggest that substrate accessibility is regulated by adjacent flexible loops. Residues important for catalysis are identified by mutation analyses, and the results provide insights into the mechanism of target site selection. We also report a nucleotide (dCMP)-bound crystal structure that informs a multistep model for binding single-stranded DNA. Overall, these high resolution crystal structures provide a framework for further mechanistic studies and the development of novel anti-cancer drugs to inhibit this enzyme, dampen tumor evolution, and minimize adverse outcomes such as drug resistance and metastasis.
PubMed: 26416889
DOI: 10.1074/jbc.M115.679951
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.08 Å)
構造検証レポート
Validation report summary of 5cqd
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon